The Washington Post explores new options for young women going through cancer treatment who want to know about their options for having children after treatment. The article looks at emerging methods and ways to approach the conversation with your doctor. Read the article here.
Building on previously presented work, researchers at M.D. Anderson Cancer Center in Houston have published new findings that show that evaluating the change of CA-125 over time shows promise as a screening tool for early-stage ovarian cancer. OCRF grantees Karen Lu, MD and Robert Bast, MD were first and senior author on the paper, which … Continued
The Petersen family was inspired to educate the world about small cell ovarian cancer while their daughter and sister Stephanie was undergoing treatment for the disease. “The first thing they said to us was, ‘Don’t look on the internet—you won’t find anything about small cell ovarian cancer,’ ” recalls Maren Petersen. Discouraged by the lack … Continued
In a review article published online in Oncogene on August 12, OCRF-funded researchers provide a comprehensive review of pre-clinical models used in ovarian cancer research. The authors, including OCRF grantees Ernst Lengyel, Daniela Matei, Ken Nephew, and Joanna Burdette, explore current experimental models and reflect on the strengths and weaknesses for each method. In addition, … Continued
Two dogs at the University of Pennsylvania’s Penn Vet Working Dog Center are learning how to smell tissue that is in early stages of ovarian cancer. The dogs have been able to smell the cancerous tissue 100% of the time. The dogs are part of an interdisciplinary research project to help scientists discover a chemical … Continued
Researchers in Austria investigated whether the time interval from surgery to start of chemotherapy has an impact on clinical outcome in patients with advanced serous ovarian cancer. Data from 191 patients with stage III or IV ovarian cancer who underwent surgery followed by platinum-based chemotherapy were analysed. The results, which were published in Gynecologic Oncology on … Continued
Alicia Baines was inspired to start Promises of Hope by the people in her community: “I recognized that my community is in need,” she recalls. “People are afraid to talk about cancer. It’s not until someone passes away that they realize they probably should have done more.” Promises of Hope is dedicated to serving Prince … Continued
Dr. Coleman, a member of the Alliance’s Scientific and Medical Advisory Board, conducted an interview on ovarian cancer therapies for the Cancer Network. He discussed the heterogeneity of ovarian cancer, angiogenesis inhibitors and new drugs in the pipeline. The full interview can be found here
Research published online last week in Nature Communications suggests that some of the cell lines most frequently used to study high-grade serous ovarian cancer (HGSOC) may not be the best. OCRF grantee and SAC member Douglas Levine, MD was one of the authors of the paper. Cell lines derived from tumor tissue are the most … Continued
In an article published last week in The Lancet, an international group of investigators examined whether ovarian cancer tumors’ expression of the progesterone receptor (PR) and estrogen receptor (ER) was associated with survival in various subtypes of ovarian cancer. To date, few biomarkers of ovarian cancer prognosis have been established. The study, which included 2,933 women, … Continued
“November 4, 1999 was one of those perfect autumn days in New York when it seems as though nothing could go wrong. But it did for me. That was the day I was diagnosed with ovarian cancer and the world as I knew it would never be the same,” says Valerie. “No one could have … Continued
Gynecologic Cancer Patients to Receive New Support in Tampa, Fla. and in Stanford, Calif. WEST CHESTER, Pa (Thursday, July 11, 2013) —Ovarian Cancer Research Fund (OCRF) and QVC today announced two new Woman to Woman grant recipients, Moffitt Cancer Center in Tampa, Fla. and Stanford Women’s Cancer Center in Stanford, Calif. QVC united with OCRF … Continued
Get email updates about research news, action alerts, and ways to join the fight.
